Diltiazem and Simvastatin Interaction

Drug interaction information between Diltiazem and Simvastatin.

Diltiazem and Simvastatin have a documented major interaction in FDA labeling.

FDA drug labeling documents a major-severity interaction between Diltiazem and Simvastatin. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Diltiazem

Calcium Channel Blocker

Drug B

Simvastatin

HMG-CoA Reductase Inhibitor (Statin)

How They Interact

Diltiazem blocks the enzymes that break down simvastatin, causing the drug to stay in your body longer. This can lead to a higher risk of muscle pain or damage.

FDA Label Information

Intervention: For patients taking verapamil, diltiazem, or dronedarone, do not exceed ezetimibe and simvastatin 10 mg/10 mg daily.

Frequently Asked Questions

What SPL severity band is on file for Diltiazem + Simvastatin?

Compiled FDA labeling labels this pair major. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Diltiazem has 46 labeled pairs on file vs Simvastatin's 41. In the major band specifically: Diltiazem has 4 (also Ezetimibe, Ezetimibe/Simvastatin, Theophylline); Simvastatin has 11 (also Verapamil, Cyclosporine, Amiodarone, Dronedarone).

What mechanism field is on file for Diltiazem and Simvastatin?

Diltiazem blocks the enzymes that break down simvastatin, causing the drug to stay in your body longer. This can lead to a higher risk of muscle pain or damage.

Simvastatin carries more major-labeled pairs than Diltiazem

SPL source-record counts only. This page's band is major · classes on file: Diltiazem (Calcium Channel Blocker); Simvastatin (HMG-CoA Reductase Inhibitor (Statin)).

Simvastatin has 11 major-labeled pairs vs Diltiazem's 4.

Diltiazem

4 major · 7 moderate · 35 minor · 46 total

Simvastatin

11 major · 9 moderate · 21 minor · 41 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.